Minapharm Pharmaceuticals’ consolidated profits jump 27.4% YoY in 9 months
Updated 11/29/2022 10:23:00 AM
Arab Finance: Minapharm Pharmaceuticals (Minapharm) (MIPH) posted a 27.37% year-on-year (YoY) growth in consolidated profit attributable to the parent company during the first nine months of 2022, according to financial statements filed to the Egyptian Exchange (EGX) on Tuesday.
The company’s consolidated profit excluding minority interest surged to EGP 448.81 million in nine months to September 30th from EGP 352.366 million a year earlier.
Operating revenues soared to EGP 2.645 billion in January-September from EGP 2.209 billion the year before.
Minapharm Pharmaceuticals is an Egypt-based company engaged in the production and distribution of pharmaceutical products. It distributes its products within and outside Egypt.
